UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

MicroRNAs as anti-cancer therapy

Current pharmaceutical design, 2014-01, Vol.20 (33), p.5328

2014

Volltextzugriff (PDF)

A KRAS-responsive long non-coding RNA controls microRNA processing

Nature communications, 2021-04, Vol.12 (1), p.2038-2038, Article 2038

2021

Volltextzugriff (PDF)

microRNA-205 Regulates HER3 in Human Breast Cancer

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (6), p.2195-2200

2009

Volltextzugriff (PDF)

Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells

Scientific reports, 2021-03, Vol.11 (1), p.5374-5374, Article 5374

2021

Volltextzugriff (PDF)

MicroRNAs in cancer

Annual review of pathology, 2014-01, Vol.9 (1), p.287-314

2014

Volltextzugriff (PDF)

Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT

Nucleosides, nucleotides & nucleic acids, 2020-02, Vol.39 (1-3), p.407-425

2020

Volltextzugriff (PDF)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset

Cancers, 2019-04, Vol.11 (4), p.483

2019

Volltextzugriff (PDF)

MicroRNA signatures in human ovarian cancer

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (18), p.8699-8707

2007

Volltextzugriff (PDF)

The Role of microRNAs in the Tumorigenesis of Ovarian Cancer

Frontiers in oncology, 2013-01, Vol.3, p.153-153

2013

Volltextzugriff (PDF)

Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

Nature communications, 2017-04, Vol.8 (1), p.14909-14909, Article 14909

2017

Volltextzugriff (PDF)

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (41), p.16570-16575

2012

Volltextzugriff (PDF)

MicroRNA profiles discriminate among colon cancer metastasis

PloS one, 2014-06, Vol.9 (6), p.e96670-e96670

2014

Volltextzugriff (PDF)

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

PloS one, 2013-06, Vol.8 (6), p.e67581

2013

Volltextzugriff (PDF)

A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer

Proceedings of the National Academy of Sciences - PNAS, 2015-06, Vol.112 (26), p.E3355-E3364

2015

Volltextzugriff (PDF)

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

Scientific reports, 2017-06, Vol.7 (1), p.3140-11, Article 3140

2017

Volltextzugriff (PDF)

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

PloS one, 2022, Vol.17 (4), p.e0267628-e0267628

2022

Volltextzugriff (PDF)

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer

Molecular oncology, 2012-08, Vol.6 (4), p.458-472

2012

Volltextzugriff (PDF)

Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature

Cancers, 2023-02, Vol.15 (4), p.1086

2023

Volltextzugriff (PDF)

Loss of miR-204 expression is a key event in melanoma

Molecular cancer, 2018-03, Vol.17 (1), p.71-71, Article 71

2018

Volltextzugriff (PDF)

Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

Nature communications, 2019-07, Vol.10 (1), p.3151-2, Article 3151

2019

Volltextzugriff (PDF)

Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition

EMBO molecular medicine, 2020-07, Vol.12 (7), p.e11099-n/a

2020

Volltextzugriff (PDF)

UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines

Genes, 2021-12, Vol.12 (12), p.1978

2021

Volltextzugriff (PDF)

Genetic Loss of miR-205 Causes Increased Mammary Gland Development

Non-coding RNA, 2023-12, Vol.10 (1), p.4

2023

Volltextzugriff (PDF)

MicroRNA in cancer: New hopes for antineoplastic chemotherapy

Upsala journal of medical sciences, 2012-05, Vol.117 (2), p.202-216

2012

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(75)
Buchkapitel
(2)

Sprache

Englisch
(77)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Humans
(35)
Life Sciences & Biomedicine
(31)
Micrornas - Genetics
(23)
Tumors
(17)
Female
(16)
Animals
(15)
Gene Expression
(14)
Microrna
(14)
Oncology
(14)
Apoptosis
(13)
Micrornas - Metabolism
(13)
Cell Line, Tumor
(12)
Micrornas
(12)
Breast Cancer
(11)
Cell Proliferation
(11)
Kinases
(11)
Gene Expression Regulation, Neoplastic
(10)
Lung Cancer
(10)
Cancer
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MicroRNAs as anti-cancer therapy

A KRAS-responsive long non-coding RNA controls microRNA processing

microRNA-205 Regulates HER3 in Human Breast Cancer

Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells

MicroRNAs in cancer

Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset

MicroRNA signatures in human ovarian cancer

The Role of microRNAs in the Tumorigenesis of Ovarian Cancer

Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status

MicroRNA profiles discriminate among colon cancer metastasis

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer

Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature

Loss of miR-204 expression is a key event in melanoma

Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition

UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines

Genetic Loss of miR-205 Causes Increased Mammary Gland Development

MicroRNA in cancer: New hopes for antineoplastic chemotherapy

Suchergebnisse filtern